Remember
 
+
 
+
 Do You Know the Most Important and Timely Stock Plays During the Trading Week? View Our Power Rankings.
 
anonusers Placed a 'Sell' Sentiment on UNVC1 day ago
anonusers Placed a 'Buy' Sentiment on HOME3 days ago
anonusers Placed a 'Sell' Sentiment on WBA3 days ago
russurban Placed a 'Buy' Sentiment on VXRT3 days ago
russurban Placed a 'Buy' Sentiment on OTLK3 days ago
russurban Followed OTLK3 days ago
stockarticles Placed a 'Buy' Sentiment on BB3 days ago
stockarticles Followed BB3 days ago
stockarticles Placed a 'Buy' Sentiment on SNAPMore than a week ago
 
Most Discussed Stocks through Posts and Reactions on SpeculatingStocks  VXRT  •  OTLK  •  PINS  •  BB  •  TWTR  •  CGC  •  ARCI  •  LULU  •  SNAP  •  IRBT
     
 

CVS Reporting Earnings Before the Bell

 
 
 

CVS, CVS Health Corp.

CVS crossed its 200-day MA with its earnings on tap before the bell.

Released on Wednesday, February 20, 2019, 5:30 AM ET
by Email Russ UrbanContact SpeculatingStocks



Pittsburgh, PA (SpeculatingStocks) - CVS Health Corp. (NYSE:CVS) looks cheap heading into earnings before the bell in a few hours today. CVS trades at a PE of less than 25 with a current PE of 22.98. CVS is trading at only about 2.5x book value. The company has grown revenue the last three quarters from $45.6 billion to $46.7 billion and to $47.2 billion in its most recent quarter. Profit last quarter came in at $1.39 billion. You can see why the excitement for CVS earnings is building.

Earnings per share out of CVS is expected to be between $1.24 and $1.26 for Q4, according to analysts. Back on November 28th, CVS completed its acquisition of Aetna. CVS has been moving from being a prescription pharmacy to a healthcare company. CVS with this earnings report can be proven to be a best of breed healthcare company trading at a market cap of $90 billion.



CVS just crossed over its 200-day moving average on Tuesday, February 19th. CVS shares traded north of $100 in 2015, and have a 52-week high of $82.15.

Look out for positive earnings out of CVS. If so, it will go a long way towards Wall Street viewing CVS as a best of breed company throughout 2019.

Join the discussion of stocks and topics mentioned in this article within:



"The Poor Man's Bloomberg Terminal":


Discover more stocks on the:

⇒ About the Author of this News Article:

Russ Urban has been following the stock market for over 18 years and holds a Bachelor's Degree in Finance. From a young age, he watched CNBC with a keen eye and became obsessed with the market and technology. Russ Urban has written hundreds of stock articles and stock picks through the years since he founded SpeculatingStocks.com, Inc. in 2006 and holds strong faith in the power of the markets and capitalism.

 If you like what you read, please share this article on social media via top right buttons in the header of this page or share speculatingstocks.com in other ways. Thank you. We depend on the help of our visitors. Much appreciated.